Market revenue in 2023 | USD 9.5 million |
Market revenue in 2030 | USD 12.7 million |
Growth rate | 4.3% (CAGR from 2023 to 2030) |
Largest segment | Cytology brushes |
Fastest growing segment | Transbronchial Needle Aspiration (TBNA) Needles |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Biopsy Forceps, Transbronchial Needle Aspiration (TBNA) Needles, Cytology Brushes |
Key market players worldwide | Olympus Corp, Boston Scientific Corp, Conmed Corp, Medtronic PLC, Becton Dickinson & Co, Hobbs Medical, Cook Medical, Telemed Systems, Argon Medical Devices, Horizons International |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to bronchial biopsy devices market will help companies and investors design strategic landscapes.
Cytology brushes was the largest segment with a revenue share of 51.58% in 2023. Horizon Databook has segmented the Norway bronchial biopsy devices market based on biopsy forceps, transbronchial needle aspiration (tbna) needles, cytology brushes covering the revenue growth of each sub-segment from 2018 to 2030.
The bronchial biopsy devices market in Norway benefits from the country’s well-established healthcare system and high standards of medical care. Norway’s emphasis on early detection and prevention of lung diseases, including lung cancer, is expected to drive the demand for advanced bronchial biopsy technologies.
Key institutions such as Oslo University Hospital are pivotal in adopting and implementing cutting-edge biopsy devices for accurate diagnosis. Norwegian medical device companies, such as Mediplast, are involved in providing specialized bronchial biopsy tools tailored to the needs of local healthcare providers.
The high incidence of respiratory diseases in Norway, influenced by factors such as smoking and industrial emissions, underscores the importance of effective diagnostic methods. The Norwegian Medicines Agency (Legemiddelverket) ensures that all medical devices, including bronchial biopsy tools, comply with stringent safety and efficacy standards.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway bronchial biopsy devices market , including forecasts for subscribers. This country databook contains high-level insights into Norway bronchial biopsy devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account